NYSE:LLY 9 August 2025 - 25 February 2026

GPCR Stock Jumps As Obesity-Drug Race Gets A New Twist
·····

GPCR Stock Jumps As Obesity-Drug Race Gets A New Twist

Structure Therapeutics Inc. shares rose 5.3% to $38.79 in late New York trading on Thursday, outpacing the broader biotech tape as investors kept the drug developer in the obesity-pill trade. The stock touched $38.85, with volume of about 499,000 shares. The move came with no new company release in the past two days. That matters because the next real test for Structure is not a same-day headline, but whether aleniglipron, its experimental oral GLP-1 drug, can move cleanly into Phase 3 and hold up against larger rivals.
May 21, 2026
Drugmakers say AI is shaving weeks off clinical trials and regulatory submissions
········

Drugmakers say AI is shaving weeks off clinical trials and regulatory submissions

Drugmakers are increasingly relying on artificial intelligence to accelerate clinical trials and regulatory filings, slashing weeks off processes that often slow down development, according to executives and analysts. While AI hasn’t yet cracked the code for discovering groundbreaking new drugs, it’s already making a dent in the “messy middle” of drug development. This matters since the timeline remains brutal. Companies report that developing a drug can take around a decade and cost close to $2 billion. Even when results seem promising, the slow grind of trial setup and paperwork can drag timelines out much longer.
January 26, 2026
Groundbreaking treatments - super crops - and a revolution in green technology
·········

Biotech 2025: Breakthrough Cures, Super Crops, and a Green Tech Revolution

The biotechnology industry is entering a new golden age in 2025, with innovations reshaping healthcare, agriculture, environmental management, and manufacturing. Globally, biotech is booming – the market is projected to expand from about $483 billion in 2024 to $546 billion in 2025, a robust growth rate of roughly 13% labiotech.eu. This rapid rise is fueled by game-changing advances: life-saving gene therapies and mRNA vaccines in medicine, gene-edited “super crops” boosting food security, and bio-based solutions that turn pollution into products. Major players from nimble startups to pharma giants are racing to commercialize breakthroughs, while investors pour capital into promising ventures. The public is increasingly seeing biotechnology’s impact everywhere – from the doctor’s office to the dinner plate – making 2025
August 9, 2025